Category: Joint ventures/collaborations
-
Asthma/Hay Fever Genetic Risk Factors Identified
28 January 2014. An analysis of genomes of people having both asthma and hay fever, compared to those with neither disease, highlighted 11 genetic variations associated with the dual-disease condition, including two previously unconnected regions. The findings from QIMR Berghofer Medical Research Institute in Australia, with colleagues from Australia, the U.K., and U.S., including the…
-
Manhattan Scientifics, MD Anderson Test Cancer Diagnostics
27 January 2014. Medical technologies developer Manhattan Scientifics in Albuquerque and MD Anderson Cancer Center in Houston are collaborating on tests of a new device that the company says detects tumors thousands of times smaller than current technologies. Financial aspects of the deal between Manhattan’s subsidiary Senior Scientific LLC that developed the device and MD Anderson…
-
Cancer Organizations, Biotech Partner on Drug Discovery
Institute of Cancer Research and Cancer Research Technology in London, and the drug discovery company Nuevolution A/S in Copenhagen, are collaborating on identifying leads for new cancer treatments that act on a promising biological pathway. The agreement includes the option to co-develop therapies from candidates identified in the project, but financial aspects of the deal…
-
EU-Funded Project to Develop Biomaterials for Stents
Ceram, a materials technology company in Stoke-on-Trent in the U.K., is coordinating a project funded by the European Commission to develop new biocompatible materials suitable for stents that help keep blood vessels open in the heart. The project, known as Rebiostent, is receiving €4.58 million of its €5.87 million ($US 6.19 million of $7.93 million)…
-
European Venture Licenses Biotech Drought-Resistant Traits
Genective, a joint venture between German and French seed companies to develop new corn varieties, is licensing engineered gene science from the biotechnology company Arcadia Biosciences Inc. in Davis, California. Arcadia Biosciences will receive initial, milestone, and sales royalty payments under the agreement, but the dollar amount of the deal was not disclosed. Arcadia Biosciences…
-
Biotech, National Lab Partner on Gas-to-Liquid Conversion
Calysta Energy, a biotechnology company in Menlo Park, California and Lawrence Livermore National Laboratory in Livermore, California are developing a biological process for converting methane to liquid fuel. Financial aspects of the agreement were not disclosed. Livermore National Lab is a facility of the U.S. Department of Energy. The project aims to devise a technique…
-
South Carolina Partnership Licenses First Technology
SCRA, a South Carolina state business investment organization in Columbia, and TAO Life Sciences, a medical device commercialization company in Greenville, say they completed their first licensing deal for a chest drainage tube device invented by students at Clemson University. Financial aspects of the licensing agreement were not disclosed. Bioengineering students at Clemson University designed…
-
Regeneron, Geisinger Health to Partner on Genetic Sequencing
Regeneron Pharmaceuticals Inc. in Tarrytown, New York and Geisinger Health System, a health care provider in Pennsylvania, are studying genetic causes of disease among the 2.6 million residents in areas served by Geisinger’s facilities. Financial terms of the five-year agreement were not disclosed. Under the deal, Geisinger will collect blood specimens from 100,000 Geisinger patients…
-
UCSF, Quest Diagnostics to Partner on Precision Medicine
Medical diagnostics provider Quest Diagnostics in Madison, New Jersey and University of California in San Francisco are researching new tests based on genetic and molecular indicators to better find genetic causes of developmental disorders like autism, and identify children with brain tumors who can best respond to treatments. The collaboration is the first for UCSF…
-
Columbia Team to Study Electric Power Switching Transistors
An engineering research group at Columbia University in New York received a $3 million grant from U.S. Department of Energy to create high-power electric switching devices with the speed and efficiency of electronic transistor circuits. The team led by electrical and biomedical engineering professor Ken Shepard — that includes members from MIT, IBM, and the…